NeuroPace, Inc.
USD16.03
-0.50 (-3.02%)
CEO
Joel D. Becker
IPO Date
2021-04-22
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$16.67
Prev. Close
$16.53
Day Low
$15.92
Day High
$16.67
52W Low
$7.56
52W High
$19.60
Market Cap
$0.55B
Volume
0.03M
| -12.0 |
| 31 Dec 2023 | FY | 73.6% | -50.4% | -159.6% | -30.6% | 3.51 | 5.71 | -8.1 |
| 31 Dec 2022 | FY | 71.4% | -103.4% | -135.4% | -41.3% | 2.01 | 8.90 | -0.8 |
| 31 Dec 2021 | FY | 74.0% | -79.9% | -49.1% | -27.0% | 0.68 | 14.28 | -4.6 |
| 31 Dec 2020 | FY | 73.6% | -59.0% | 16.4% | -43.4% | -0.36 | 5.69 | -11.4 |
| 31 Dec 2019 | FY | 71.6% | -81.1% | 23.2% | -142.1% | -0.49 | 0.27 | -9.2 |
| -46.3 |
| 30 Sept 2025 | Q3 | 77.4% | -12.8% | -18.9% | -3.3% | 3.84 | 4.86 | -24.4 |
| 30 Jun 2025 | Q2 | 77.1% | -36.8% | -44.5% | -8.2% | 3.68 | 5.47 | -10.6 |
| 31 Mar 2025 | Q1 | 77.0% | -29.3% | -27.1% | -6.0% | 3.01 | 6.63 | -14.7 |
| 31 Dec 2024 | Q4 | 75.4% | -24.5% | -65.5% | -5.5% | 9.15 | 5.37 | -15.9 |
| 30 Sept 2024 | Q3 | 73.2% | -25.9% | -55.5% | -5.7% | 7.48 | 5.59 | -9.4 |
| 30 Jun 2024 | Q2 | 73.4% | -39.0% | -76.0% | -8.0% | 7.45 | 6.37 | -7.0 |
| 31 Mar 2024 | Q1 | 73.6% | -49.2% | -62.2% | -9.0% | 5.10 | 6.43 | -10.8 |
| 31 Dec 2023 | Q4 | 75.2% | -34.4% | -30.0% | -5.8% | 3.51 | 5.71 | -10.8 |